• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤分级、分期、数量和大小以及吸烟与性别对膀胱移行细胞癌患者生存率的影响。

Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.

作者信息

Raitanen M P, Nieminen P, Tammela T L

机构信息

Department of Surgery, Seinäjoki Central Hospital, Tampere, Finland.

出版信息

Br J Urol. 1995 Oct;76(4):470-4. doi: 10.1111/j.1464-410x.1995.tb07748.x.

DOI:10.1111/j.1464-410x.1995.tb07748.x
PMID:7551884
Abstract

OBJECTIVE

To evaluate the impact of the grade, stage number and size of the tumour and of smoking and sex of patient on survival, and the relationship between smoking and tumour grade, stage, number and size, and sex of patient in patients with transitional cell carcinoma (TCC) of the urinary bladder.

PATIENTS AND METHODS

The study comprised 252 consecutive patients with histologically verified TCC of the bladder reporting to Oulu University Central Hospital between 1978 and 1986. The average duration of follow-up was 6.7 years. The association between smoking and other covariates was analysed by cross-tabulation and standard chi-squared analyses. The Kaplan-Meier method was used to obtain estimated survival curves and significant differences determined using log rank statistics.

RESULTS

Smoking had no impact on tumour grade, stage, size and number or aggressiveness of metastases. Prognosis was noticeably better if the patient did not smoke, as 27% of the non-smokers and 40% of the smokers had died during the first 10 years after diagnosis. Survival was also better in patients with low grade (I, II), non-invasive (Ta/T1) and small (< or = 3 cm) tumours.

CONCLUSION

In addition to the well-known prognostic factors (histological grade and stage of the tumour), smoking is a risk factor for bladder cancer and also has an impact on prognosis, leading to higher mortality from the disease in the longer term.

摘要

目的

评估肿瘤分级、分期数量及大小以及患者吸烟情况和性别对生存的影响,以及吸烟与膀胱移行细胞癌(TCC)患者肿瘤分级、分期、数量、大小及患者性别的关系。

患者与方法

本研究纳入了1978年至1986年间连续就诊于奥卢大学中心医院的252例经组织学证实的膀胱TCC患者。平均随访时间为6.7年。通过交叉表和标准卡方分析来分析吸烟与其他协变量之间的关联。采用Kaplan-Meier方法获得估计生存曲线,并使用对数秩统计量确定显著差异。

结果

吸烟对肿瘤分级、分期、大小、数量或转移侵袭性无影响。如果患者不吸烟,预后明显更好,因为在诊断后的前10年中,27%的非吸烟者和40%的吸烟者死亡。低级别(I、II级)、非侵袭性(Ta/T1)和小(≤3 cm)肿瘤患者的生存情况也更好。

结论

除了众所周知的预后因素(肿瘤的组织学分级和分期)外,吸烟是膀胱癌的一个危险因素,并且对预后也有影响,从长远来看会导致该疾病更高的死亡率。

相似文献

1
Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.肿瘤分级、分期、数量和大小以及吸烟与性别对膀胱移行细胞癌患者生存率的影响。
Br J Urol. 1995 Oct;76(4):470-4. doi: 10.1111/j.1464-410x.1995.tb07748.x.
2
The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.肿瘤扩散、分级及生长模式作为膀胱癌形态学预测参数的价值。对1987年TNM分类的批判性修订。
J Cancer Res Clin Oncol. 1993;119(10):578-93. doi: 10.1007/BF01372721.
3
Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.肿瘤相关组织炎症反应在移行性膀胱细胞癌中的预后作用。
Oncol Rep. 2006 Aug;16(2):329-34.
4
The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.肿瘤分级在预测膀胱Ta期移行细胞癌疾病进展中的意义。
Br J Urol. 1996 Aug;78(2):209-12. doi: 10.1046/j.1464-410x.1996.10511.x.
5
p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma.p53和ki67表达作为T1期移行细胞膀胱癌癌症相关生存的预后因素
Eur Urol. 2002 Feb;41(2):182-8; discussion 188-9. doi: 10.1016/s0302-2838(01)00038-0.
6
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.根据日本登记膀胱癌患者的数据得出的Ta、T1期非肌层浸润性膀胱癌肿瘤复发的临床结果:日本泌尿外科学会1999 - 2001年报告
Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.
7
Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.印度尼西亚膀胱移行细胞癌患者的生存情况:单机构回顾分析
Asian Pac J Cancer Prev. 2011;12(2):549-53.
8
[Clinical course and mid- and long-term prognosis of superficial bladder tumors].[浅表性膀胱肿瘤的临床病程及中长期预后]
Actas Urol Esp. 2001 Nov-Dec;25(10):710-9. doi: 10.1016/s0210-4806(01)72706-4.
9
p53 expression predicts progression and poor survival in T1 bladder tumours.p53表达可预测T1期膀胱肿瘤的进展及不良预后。
Eur Urol. 2000 Jun;37(6):644-53. doi: 10.1159/000020232.
10
[Clinical prognostic factors in superficial cancer of the urinary bladder].
Arch Esp Urol. 2001 Mar;54(2):131-8.

引用本文的文献

1
Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.生活方式与非肌层浸润性膀胱癌的复发、进展及死亡率:现有研究与未来方向
Bladder Cancer. 2020;6(1):9-23. doi: 10.3233/blc-190249. Epub 2020 Mar 28.
2
[Prognostic value of preoperative serum albumin in patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumor].[术前血清白蛋白对行经尿道膀胱肿瘤切除术的非肌层浸润性膀胱癌患者的预后价值]
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Feb 20;38(2):192-197. doi: 10.3969/j.issn.1673-4254.2018.02.12.
3
[Secondary prevention in patients with superficial urothelial carcinoma].
[浅表性尿路上皮癌患者的二级预防]
Urologe A. 2015 Jul;54(7):992-7. doi: 10.1007/s00120-015-3839-7.
4
Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer.病理淋巴结阴性膀胱癌根治性膀胱切除术后预后的预测。
Int Urol Nephrol. 2011 Dec;43(4):1059-65. doi: 10.1007/s11255-011-9920-2. Epub 2011 May 28.
5
Cigarette smoking and subtypes of bladder cancer.吸烟与膀胱癌亚型。
Int J Cancer. 2012 Feb 15;130(4):896-901. doi: 10.1002/ijc.26068. Epub 2011 May 9.
6
Patient awareness of smoking as a risk factor for bladder cancer.患者对吸烟作为膀胱癌风险因素的认识。
Int Urol Nephrol. 2010 Jun;42(2):309-14. doi: 10.1007/s11255-009-9611-4. Epub 2009 Jul 10.
7
Epidemiology of urinary bladder cancer: from tumor development to patient's death.膀胱癌流行病学:从肿瘤发生到患者死亡
World J Urol. 2007 Jun;25(3):285-95. doi: 10.1007/s00345-007-0168-5.
8
Chemoprevention of bladder cancer.膀胱癌的化学预防
World J Urol. 2006 Nov;24(5):445-72. doi: 10.1007/s00345-006-0123-x.
9
Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.G蛋白β3亚基C825T基因多态性与膀胱癌患者疾病进展的关联研究
World J Urol. 2005 Sep;23(4):279-86. doi: 10.1007/s00345-005-0006-6. Epub 2005 Nov 8.
10
The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.膀胱移行细胞癌患者全身炎症反应与生存率的关系。
Br J Cancer. 2005 Feb 28;92(4):625-7. doi: 10.1038/sj.bjc.6602406.